Sandler Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,892
Closed -$4.2M 183
2024
Q3
$4.2M Buy
+25,892
New +$4.13M 0.55% 73
2017
Q3
Sell
-5,310
Closed -$702K 133
2017
Q2
$702K Hold
5,310
0.08% 117
2017
Q1
$661K Buy
5,310
+2,975
+127% +$355K 0.05% 158
2016
Q4
$269K Buy
2,335
+135
+6% +$15.6K 0.02% 142
2016
Q3
$260K Sell
2,200
-51,800
-96% -$6.28M 0.03% 105
2016
Q2
$6.55M Buy
+54,000
New +$6.14M 0.86% 47

Other funds holding JNJ

Sandler Capital Management's JNJ Position: Q4 2024 in Review

Sandler Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 25,892 shares — an estimated $4.2M sold.

Sandler Capital Management first reported a position in JNJ in Q2 2016 and held it in 6 quarters. The position peaked at $6.55M in Q2 2016. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Sandler Capital Management reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Sandler Capital Management sold 25,892 Johnson & Johnson shares in Q4 2024, an estimated $4.2M.
  • Sandler Capital Management first reported a position in Johnson & Johnson in Q2 2016 and held it in 6 quarters.
  • Sandler Capital Management's Johnson & Johnson position peaked at $6.55M in Q2 2016.
  • 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Sandler Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.